Graft-versus-host Disease (GVHD)

DBCOND0088786Immune System DiseasesWounds and Injuries

Graft-versus-host Disease (GVHD) is the indication for 7 drugs in DrugBank. It is covered by 10 curated, structured indications.

Also known as
Graft-Versus-Host Disease · Graft vs. Host Disease (GvHD) · Graft-Vs-Host Disease · Graft-vs-Host Disease (GVHD) · Graft Versus Host Disease (GVHD)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT018469ICD-10D89.81SNOMED CT234646005MedDRA10018651UMLSC0018133

What you can answer from here — as of October 25, 2026

7Indicated drugsWith each drug's targets and mechanism
Listed above
10Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
478Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Boxed warningsLabel boxed warnings that name this condition
Sign in
9Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Graft-versus-host Disease (GVHD) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In